David Batt

1.6k total citations
21 papers, 1.3k citations indexed

About

David Batt is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, David Batt has authored 21 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Oncology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in David Batt's work include Cancer Mechanisms and Therapy (5 papers), Melanoma and MAPK Pathways (5 papers) and Synthesis and biological activity (3 papers). David Batt is often cited by papers focused on Cancer Mechanisms and Therapy (5 papers), Melanoma and MAPK Pathways (5 papers) and Synthesis and biological activity (3 papers). David Batt collaborates with scholars based in United States, Switzerland and Germany. David Batt's co-authors include Thomas M. Roberts, Francisca Vázquez, Shivapriya Ramaswamy, William R. Sellers, Noriaki Nakamura, Gordon Carmichael, Naeem Yusuff, Nanxin Li, Soner Altiok and Markus Warmuth and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

David Batt

21 papers receiving 1.3k citations

Peers

Countries citing papers authored by David Batt

Since Specialization

Citations

This map shows the geographic impact of David Batt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Batt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Batt more than expected).

Fields of papers citing papers by David Batt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Batt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Batt. The network helps show where David Batt may publish in the future.

Co-authorship network of co-authors of David Batt

This figure shows the co-authorship network connecting the top 25 collaborators of David Batt. A scholar is included among the top collaborators of David Batt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Batt. David Batt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract 1680: In vitro and in vivo activity of a highly potent and novel FGFR2/FGFR4 dual targeting antibody-drug conjugate 2015 ·Cancer Research ·Matthew J. Meyer, David F. Jenkins, David Batt, Rebecca Mosher, Randi Isaacs, Tiancen Hu, Vladimı́r Čápka, Xiamei Zhang, Dongshu Chen, (unknown), Mike Daley, (unknown), (unknown), Wei Jiang, Seth A. Ettenberg, Emma Lees	4
2	An Activated ErbB3/NRG1 Autocrine Loop Supports In Vivo Proliferation in Ovarian Cancer Cells 2010 ·Cancer Cell ·Qing Sheng, Xinggang Liu, Eleanor Fleming, Karen Yuan, Huiying Piao, Jinyun Chen, (unknown), Roman K. Thomas, Heidi Greulich, Anna C. Schinzel, Sara Zaghlul, David Batt, Seth A. Ettenberg, Matthew Meyerson, Birgit Schoeberl, Andrew L. Kung, William C. Hahn, Ronny Drapkin, David M. Livingston, Joyce F. Liu	178
3	An Activated ErbB3/NRG1 Autocrine Loop Supports In Vivo Proliferation in Ovarian Cancer Cells 2010 ·Cancer Cell ·Quan Z. Sheng, Xinggang Liu, (unknown), Karen Yuan, Huiying Piao, Jinyun Chen, (unknown), Roman K. Thomas, Heidi Greulich, Anna C. Schinzel, Sara Zaghlul, David Batt, Seth A. Ettenberg, Matthew Meyerson, Andrew L. Kung, William C. Hahn, Ronny Drapkin, David M. Livingston, Joyce F. Liu	10
4	Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytes 2008 ·Molecular Cancer Therapeutics ·Sven Arke Lang, (unknown), (unknown), Akira Mori, Christina Hackl, Andreas Gäumann, David Batt, Hans J. Schlitt, Edward K. Geissler, Oliver Stoeltzing	46
5	Dual inhibition of Raf and VEGFR2 reduces growth and vascularization of hepatocellular carcinoma in an experimental model 2008 ·Langenbeck s Archives of Surgery ·Sven Arke Lang, (unknown), (unknown), Aiman Obed, David Batt, (unknown), Edward K. Geissler, Oliver Stoeltzing	8
6	Targeting BRAFV600E in thyroid carcinoma: therapeutic implications 2007 ·Molecular Cancer Therapeutics ·Constantine S. Mitsiades, Joseph Negri, Ciaran J. McMullan, Douglas W. McMillin, (unknown), Galinos Fanourakis, Gerassimos E. Voutsinas, Sofia Tseleni‐Balafouta, Vassiliki Poulaki, David Batt, Nicholas Mitsiades	43
7	B-Raf kinase inhibitors for cancer treatment. 2007 ·PubMed ·Nanxin Li, David Batt, Markus Warmuth	44
8	The combination of novel low molecular weight inhibitors of RAF (LBT613) and target of rapamycin (RAD001) decreases glioma proliferation and invasion 2007 ·Molecular Cancer Therapeutics ·Anita B. Hjelmeland, (unknown), Brian E. Fee, Qing Shi, (unknown), Stephen T. Keir, Mark D. Hjelmeland, David Batt, Darell D. Bigner, Henry S. Friedman, Jeremy N. Rich	32
9	Inhibitors of Raf Kinase Activity Block Growth of Thyroid Cancer Cells with RET/PTC or BRAF Mutations In vitro and In vivo 2006 ·Clinical Cancer Research ·Bin Ouyang, Jeffrey A. Knauf, Eric P. Smith, Lei Zhang, (unknown), Naeem Yusuff, David Batt, James A. Fagin	113
10	AAL881, a Novel Small Molecule Inhibitor of RAF and Vascular Endothelial Growth Factor Receptor Activities, Blocks the Growth of Malignant Glioma 2006 ·Cancer Research ·Sith Sathornsumetee, Anita B. Hjelmeland, Stephen T. Keir, Roger E. McLendon, David Batt, Timothy M. Ramsey, Naeem Yusuff, Binish Rasheed, Mark W. Kieran, Andrea Laforme, Darell D. Bigner, Henry S. Friedman, Jeremy N. Rich	41
11	The Synthesis of a Novel Inhibitor of B-Raf Kinase 2005 ·Organic Process Research & Development ·(unknown), (unknown), (unknown), Naeem Yusuff, David Batt, (unknown), Peng Geng, (unknown), (unknown), (unknown), Richard Versace, David Cesarz, Lawrence Perez	9
12	Platelet-derived Growth Factor Stimulation of Monocyte Chemoattractant Protein-1 Gene Expression Is Mediated by Transient Activation of the Phosphoinositide 3-Kinase Signal Transduction Pathway 1999 ·Journal of Biological Chemistry ·John A. Alberta, Kurt R. Auger, David Batt, Palma Iannarelli, (unknown), Heidi L. Elliott, Rebecca M. Duke, Thomas M. Roberts, Charles D. Stiles	23
13	Homogeneous Purification of Human Recombinant GST–Akt/PKB from Sf9 Cells 1999 ·Protein Expression and Purification ·Doriano Fabbro, David Batt, Paul Rose, (unknown), (unknown), Stefano Ferrari	17
14	Heregulin Induces Phosphorylation of BRCA1 through Phosphatidylinositol 3-Kinase/AKT in Breast Cancer Cells 1999 ·Journal of Biological Chemistry ·Soner Altiok, David Batt, Nedret Altıok, (unknown), Julian Downward, Thomas M. Roberts, Hava Avraham	106
15	Regulation of G₁progression by thePTENtumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway 1999 ·Proceedings of the National Academy of Sciences ·Shivapriya Ramaswamy, Noriaki Nakamura, Francisca Vázquez, David Batt, (unknown), Thomas M. Roberts, William R. Sellers	492
16	An Improved Rapid Method of Isolating RNA from Cultured Cells 1998 ·Humana Press eBooks ·David Batt, Gordon Carmichael, Zhong Liu	3
17	Cell Density Modulates Protein-tyrosine Phosphorylation 1998 ·Journal of Biological Chemistry ·David Batt, Thomas M. Roberts	42
18	Characterization of the Polyomavirus Late Polyadenylation Signal 1995 ·Molecular and Cellular Biology ·David Batt, Gordon Carmichael	4
19	Polyadenylation and transcription termination in gene constructs containing multiple tandem polyadenylation signals 1994 ·Nucleic Acids Research ·David Batt, Ying Luo, Gordon Carmichael	23
20	Targeted nuclear antisense RNA mimics natural antisense-induced degradation of polyoma virus early RNA. 1994 ·Proceedings of the National Academy of Sciences ·Zhifeng Liu, David Batt, Gordon Carmichael	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact